시장보고서

상품코드

1425020

응급 피임약 시장 : 제품 유형별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율 예측(2023년-2030년)

Emergency Contraceptive Pills (ECPS) Market, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

발행일: 2024년 02월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 285 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

응급 피임약 시장 규모는 2022년 10억 4,500만 달러로 평가되었고, 2023년부터 2030년까지 연평균 복합 성장률(CAGR) 2.5%로 확대될 전망입니다.

응급 피임약 시장-시장 역학

예기치 않은 임신 증가가 시장 성장의 원동력이 될 전망

의도하지 않은 임신은 개인과 사회에 상당한 사회 경제적 부담을 강요하는 심각한 세계적 문제입니다. 세계에서는 매년 약 1억 2,100만 건이 의도하지 않은 임신이며, 전체 임신의 약 절반을 차지하고 있습니다. 그 영향을 받는 여성과 소녀에게 임신 여부를 결정하는 것은 종종 선택의 여지가 없습니다. 유엔의 성과 생식에 관한 보건기구인 UNFPA가 발표한 「2022년 세계 인구의 현상」보고는 이 문제에 임하는 긴급의 필요성을 강조하고 있습니다. 예정되지 않은 임신 증가를 다루기 위해서는 피임에 대한 인식과 교육 강화가 필요합니다. 리프로덕티브 헬스(성과 생식에 관한 건강)에 대한 의식이 높아지고 피임 방법에 대한 교육이 개선되면 응급 피임약 수요를 촉진할 수 있기 때문에 시장이 성장할 수 있습니다. 그러나 부작용이나 건강 문제가 시장 성장을 방해할 수 있음을 고려하는 것이 중요합니다.

응급 피임약 시장-주요 인사이트

우리의 리서치 애널리스트가 공유한 분석에 따르면 세계의 응급 피임약 시장은 예측 기간(2023-2030년)에 약 2.5%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 예측됩니다.

제품 유형별로, 프로게스테론 정제는 2022년에 가장 큰 시장 점유율을 나타낸 것으로 평가되었습니다.

용도별로 약판매점 및 약국은 2022년의 주요 유형이었습니다.

지역별로는 북미가 2022년에 수익을 창출하는 주요 시장이었습니다.

응급 피임약(ECP) 시장-세분화 분석 :

세계의 응급 피임약 시장은 제품 유형, 용도, 지역별로 구분됩니다.

시장은 제품 유형에 따라 네 가지 범주로 나뉩니다. 콤비네이션 알약, 프로게스테론 알약, 에스트로겐 알약, 기타 등입니다. 시장은 주로 프로게스테론 알약 부문에 의해 지배됩니다. 프로게스테론 전용 알약은 통상적인 피임법으로 일반적으로 사용되지만, 보통 비상 피임약으로 사용되는 것은 아닙니다. 대신 앞서 언급했듯이 응급 피임약(ECP)은 피임없이 성교 한 후에 발생하는 응급 상황을 위해 특별히 처방됩니다.

시장은 용도에 따라 네 가지 범주로 나뉩니다. 약판매점 및 약국, 병원 약국, 온라인 업체 및 기타 채널입니다. 시장은 약판매점 및 약국 부문이 대부분을 차지하고 있습니다. 상업적인 응급 피임약(ECP)은 쉽게 입수할 수 있으며, 약국에서의 존재는 개인의 긴급 피임 요건을 충족시키기 위해 필수적입니다.

응급 피임약 시장-지리적 인사이트

지리적으로, 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동, 아프리카 등 다양한 지역으로 퍼져 있습니다. 이 지역은 사업 활동에 관여하는 국가에 따라 추가로 분할됩니다. 시장 성장은 주로 긴급 피임약 제품의 가용성이 증가하고 있는 북미가 지배적일 것으로 예상됩니다. 북미는 확립된 헬스케어 인프라를 자랑하며 긴급 피임약을 포함한 피임용품의 효율적인 유통과 입수를 용이하게 하고 있습니다. 미국에서는 성적으로 활동적인 여성의 99%가 일부 피임을 경험하고 있으며, 그 중 87.5%는 미국 산과부인과학회(American College of Obstetricians and Gynecologists)가 추천하는 효과가 높은 가역적 피임법을 선택 하고 있습니다. 예측기간에서는 유럽이 2위 시장 점유율을 차지하고 있는데, 이는 주로 피임과 가족계획에 대한 의식이 높아지기 때문입니다.

응급 피임약 시장-경쟁 구도 :

세계의 다양한 제약회사가 응급 피임약을 제조 및 판매하고 있으며, 많은 국가에서 규제당국의 승인을 얻고 있습니다. 이 시장 경쟁 구도는 생식 의료의 진보와 규제의 변화에 의해 영향을 받을 수 있습니다. 응급 피임약 경쟁 구도에 대한 최신 정보를 얻으려면 공공 보건 기관, 제약 회사 웹 사이트 및 최근 시장 보고서를 참조하는 것이 바람직합니다. ECP를 제공하는 평판 좋은 온라인 플랫폼은 소비자에게 응급 피임에 대한 편리한 액세스를 제공함으로써 경쟁에 기여할 수 있습니다. 예를 들어, 온두라스의 Optio는 Ashonplafa 네트워크 내의 의료 제공업체 및 커뮤니티 근로자의 EC 지식을 강화하기 위해 스페인어 버전의 응급 피임(EC) 교육 도구를 개발했습니다.

서문
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제10장 주요 벤더 분석-응급 피임약 업계

경쟁 대시보드
기업 프로파일
- HLL Life Care
- Pfizer
- Syzygy Healthcare
- V Care Pharma
- Allergan
- Lupin
- Mankind
- Piramal
- Teva
- Bayer AG
- Zhejiang Xianju Pharmaceutical Co.
- Cooper Pharma
- Richter Gedeon Nyrt
- Laboratoire HRA Pharma
- Uniprix

제11장 애널리스트의 전방위 전망

AJY 24.02.27

REPORT HIGHLIGHT

Emergency Contraceptive Pills (ECPS) Market size was valued at USD 1,045 Million in 2022, expanding at a CAGR of 2.5% from 2023 to 2030.

Emergency contraception refers to methods of contraception that can be used to prevent pregnancy after sexual intercourse. It is highly recommended to use these methods within 5 days, but their effectiveness is greater the sooner they are utilized after intercourse. Emergency contraceptive pills work by either preventing or delaying ovulation, and they do not induce abortion. On the other hand, the copper-bearing IUD prevents fertilization by causing a chemical alteration in both sperm and egg before they can meet. It is important to note that emergency contraception cannot terminate an established pregnancy or harm the development of an embryo. It is crucial to understand that any woman or girl of reproductive age may require emergency contraception to prevent an unwanted pregnancy. There are no absolute medical reasons to avoid using emergency contraception, and there are no age restrictions for its usage. The eligibility criteria for general use of a copper IUD also apply to its use for emergency purposes. According to the World Health Organization, emergency contraception (EC) can prevent over 95% of pregnancies when taken within 5 days after intercourse.

Emergency Contraceptive Pills (ECPS) Market- Market Dynamics

Increase in the number of unplanned pregnancies is expected to drive the growth of market

Unintended pregnancy is a significant global issue that imposes a considerable socioeconomic burden on individuals and society. Approximately 121 million pregnancies worldwide each year are unintended, accounting for nearly half of all pregnancies. For women and girls affected by this, the decision of whether or not to become pregnant is often not a choice at all. The State of World Population 2022 report, released by UNFPA, the United Nations sexual and reproductive health agency, highlights the urgent need for addressing this problem. To address the rise in unplanned pregnancies, there is a requirement for enhanced awareness and education about contraception. The market can experience growth through increased awareness about reproductive health and improved education on contraception methods, which can drive the demand for emergency contraceptive pills. However, it is important to consider that side effects and health concerns may hinder the growth of the market.

Emergency Contraceptive Pills (ECPS) Market- Key Insights

As per the analysis shared by our research analyst, the global Emergency Contraceptive Pills (ECPS) market is estimated to grow annually at a CAGR of around 2.5% over the forecast period (2023-2030)

Based on product type segmentation, Progesterone Pills was predicted to show maximum market share in the year 2022

Based on application segmentation, Drug Stores/ Pharmacy was the leading type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Emergency Contraceptive Pills (ECPS) Market- Segmentation Analysis:

The Global Emergency Contraceptive Pills (ECPS) Market is segmented on the basis of Product Type, Application and Region.

The market is divided into four categories based on product type: Combination Pills, Progesterone Pills, Estrogen Pills and Others. The market is primarily dominated by the Progesterone Pills segment. Although progesterone-only pills are commonly used as a regular contraceptive method, they are not typically employed as emergency contraception. Instead, Emergency Contraceptive Pills (ECPS), as previously mentioned, are specifically formulated for urgent situations that occur after unprotected intercourse.

The market is divided into four categories based on application: Drug Stores/ Pharmacy, Hospital Pharmacies, Online Traders and Other Channels. The market is largely dominated by the Drug Stores/Pharmacy segment. Over-the-counter Emergency Contraceptive Pills (ECPS) are readily available, and their presence in pharmacies is vital for addressing the immediate contraceptive requirements of individuals.

Emergency Contraceptive Pills (ECPS) Market- Geographical Insights

Geographically, this market is spread across various regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The growth of the market is expected to be dominated by North America, primarily due to the increasing availability of emergency contraceptive products. North America boasts a well-established healthcare infrastructure, which facilitates the efficient distribution and accessibility of contraceptive products, including emergency contraceptive pills. 99% of sexually active women in the United States have used some form of contraception, with 87.5% opting for highly effective reversible methods as recommended by the American College of Obstetricians and Gynecologists. In the forecast period, Europe holds the second largest market share, mainly attributed to the growing awareness about contraception and family planning.

Emergency Contraceptive Pills (ECPS) Market- Competitive Landscape:

Various pharmaceutical companies worldwide manufacture and distribute emergency contraceptive pills, as they have obtained regulatory approval in numerous countries. The competitive landscape of this market can be influenced by advancements in reproductive health and alterations in regulations. To obtain the latest information on the competitive landscape of Emergency Contraceptive Pills, it is advisable to refer to official health agencies, pharmaceutical company websites, and recent market reports. Reputable online platforms offering ECPs may also contribute to competition by offering consumers convenient access to emergency contraception. For example, In Honduras, Optio developed Spanish versions of emergency contraception (EC) educational tools, to strengthen EC knowledge among health providers and community workers within Ashonplafa's network.

Recent Developments:

In November 2023, the trial for a new method of distributing emergency contraception pills (ECPs) without a prescription in Japan commenced, as reported by the Kyodo news agency. The Health, Labour and Welfare Ministry will be conducting this trial in 145 pharmacies, out of the over 60,000 pharmacies in the country. It is worth noting that Japan is among the few countries in the northern hemisphere where levonorgestrel (LNG) ECPs are still classified as prescription-only medications. To gain a deeper understanding of this research and trial, ECEC had the opportunity to interview Kazuko Fukuda, a prominent advocate for women's sexual and reproductive rights in Japan.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL EMERGENCY CONTRACEPTIVE PILLS (ECPS) MARKET KEY PLAYERS

HLL Life Care
Pfizer
Syzygy Healthcare
V Care Pharma
Allergan
Lupin
Mankind
Piramal
Teva
Bayer AG
Zhejiang Xianju Pharmaceutical Co.
Cooper Pharma
Richter Gedeon Nyrt
Laboratoire HRA Pharma
Uniprix

GLOBAL EMERGENCY CONTRACEPTIVE PILLS (ECPS) MARKET, BY PRODUCT TYPE

Combination Pills
Progesterone Pills
Estrogen Pills
Others

GLOBAL EMERGENCY CONTRACEPTIVE PILLS (ECPS) MARKET, BY APPLICATION

Drug Stores/ Pharmacy
Hospital Pharmacies
Online Traders
Other Channels

GLOBAL EMERGENCY CONTRACEPTIVE PILLS (ECPS) MARKET, BY REGION

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Emergency Contraceptive Pills (ECPS) Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Emergency Contraceptive Pills (ECPS) Market Snippet by Product Type
- 2.1.2. Emergency Contraceptive Pills (ECPS) Market Snippet by Application
- 2.1.3. Emergency Contraceptive Pills (ECPS) Market Snippet by Country
- 2.1.4. Emergency Contraceptive Pills (ECPS) Market Snippet by Region
2.2. Competitive Insights

3. Emergency Contraceptive Pills (ECPS) Key Market Trends

3.1. Emergency Contraceptive Pills (ECPS) Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Emergency Contraceptive Pills (ECPS) Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Emergency Contraceptive Pills (ECPS) Market Opportunities
3.4. Emergency Contraceptive Pills (ECPS) Market Future Trends

4. Emergency Contraceptive Pills (ECPS) Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Emergency Contraceptive Pills (ECPS) Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Emergency Contraceptive Pills (ECPS) Market Landscape

6.1. Emergency Contraceptive Pills (ECPS) Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Emergency Contraceptive Pills (ECPS) Market - By Product Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
- 7.1.2. Combination Pills
- 7.1.3. Progesterone Pills
- 7.1.4. Estrogen Pills
- 7.1.5. Others

8. Emergency Contraceptive Pills (ECPS) Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
- 8.1.2. Drug Stores/ Pharmacy
- 8.1.3. Hospital Pharmacies
- 8.1.4. Online Traders
- 8.1.5. Other Channels

9. Emergency Contraceptive Pills (ECPS) Market- By Geography

9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
9.2. North America
- 9.2.1. Overview
- 9.2.2. Emergency Contraceptive Pills (ECPS) Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.2.6. U.S.
  - 9.2.6.1. Overview
  - 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.2.7. Canada
  - 9.2.7.1. Overview
  - 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3. Europe
- 9.3.1. Overview
- 9.3.2. Emergency Contraceptive Pills (ECPS) Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.6. Germany
  - 9.3.6.1. Overview
  - 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.7. Italy
  - 9.3.7.1. Overview
  - 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.8. United Kingdom
  - 9.3.8.1. Overview
  - 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.9. France
  - 9.3.9.1. Overview
  - 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.10. Russia
  - 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.11. Netherlands
  - 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.12. Sweden
  - 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.13. Poland
  - 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.14. Rest of Europe
  - 9.3.14.1. Overview
  - 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Emergency Contraceptive Pills (ECPS) Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.6. India
  - 9.4.6.1. Overview
  - 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.7. China
  - 9.4.7.1. Overview
  - 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.8. Japan
  - 9.4.8.1. Overview
  - 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.9. South Korea
  - 9.4.9.1. Overview
  - 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.10. Australia
  - 9.4.10.1. Overview
  - 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.11. Thailand
  - 9.4.11.1. Overview
  - 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.12. Indonesia
  - 9.4.12.1. Overview
  - 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.13. Philippines
  - 9.4.13.1. Overview
  - 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.14. Rest of APAC
  - 9.4.14.1. Overview
  - 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Emergency Contraceptive Pills (ECPS) Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.6. Brazil
  - 9.5.6.1. Overview
  - 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.7. Mexico
  - 9.5.7.1. Overview
  - 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.8. Argentina
  - 9.5.8.1. Overview
  - 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.9. Colombia
  - 9.5.9.1. Overview
  - 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.10. Rest of LATAM
  - 9.5.10.1. Overview
  - 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Emergency Contraceptive Pills (ECPS) Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.6. Saudi Arabia
  - 9.6.6.1. Overview
  - 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.7. United Arab Emirates
  - 9.6.7.1. Overview
  - 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.8. Israel
  - 9.6.8.1. Overview
  - 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.9. Turkey
  - 9.6.9.1. Overview
  - 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.10. Algeria
  - 9.6.10.1. Overview
  - 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.11. Egypt
  - 9.6.11.1. Overview
  - 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.12. Rest of MEA
  - 9.6.12.1. Overview
  - 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  - 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Emergency Contraceptive Pills (ECPS) Industry

10.1. Competitive Dashboard
10.2. Company Profiles
- 10.2.1. HLL Life Care
- 10.2.2. Pfizer
- 10.2.3. Syzygy Healthcare
- 10.2.4. V Care Pharma
- 10.2.5. Allergan
- 10.2.6. Lupin
- 10.2.7. Mankind
- 10.2.8. Piramal
- 10.2.9. Teva
- 10.2.10. Bayer AG
- 10.2.11. Zhejiang Xianju Pharmaceutical Co.
- 10.2.12. Cooper Pharma
- 10.2.13. Richter Gedeon Nyrt
- 10.2.14. Laboratoire HRA Pharma
- 10.2.15. Uniprix

11. 360 Degree Analyst View

12. Appendix

12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us